NuVasive, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUVA research report →
About the company
NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures.
- CEO
- J. Christopher Barry
- IPO
- 2004
- Employees
- 3,000
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $2.08B
- P/E
- 50.96
- P/S
- 1.73
- P/B
- 2.62
- EV/EBITDA
- 19.11
- Div Yield
- 0.00%
- Gross Margin
- 72.00%
- Op Margin
- 5.39%
- Net Margin
- 3.36%
- ROE
- 4.86%
- ROIC
- 2.54%
- Revenue
- $1.20B · 5.53%
- Net Income
- $40.41M · 163.05%
- EPS
- $0.78 · 162.90%
- Op Income
- $64.77M
- FCF YoY
- -57.41%
- 52W High
- $49.53
- 52W Low
- $35.17
- 50D MA
- $40.83
- 200D MA
- $41.23
- Beta
- 1.07
- Avg Volume
- 1.41M
Get TickerSpark's AI analysis on NUVA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 1, 23 | Wolterman Dan | sell | 4,816 |
| Sep 1, 23 | Raimundo Amy Belt | sell | 4,816 |
| Sep 1, 23 | Norwalk Leslie V | sell | 3,095 |
| Sep 1, 23 | Norwalk Leslie V | sell | 4,816 |
| Sep 1, 23 | Kadia Siddhartha | sell | 4,816 |
| Sep 1, 23 | Kadia Siddhartha | sell | 3,739 |
| Sep 1, 23 | Huennekens R Scott | sell | 4,816 |
| Sep 1, 23 | Huennekens R Scott | sell | 1,360 |
| Sep 1, 23 | FRIEL ROBERT F | sell | 4,816 |
| Sep 1, 23 | DeFord John A | sell | 3,788 |
Our NUVA coverage
Recent articles, reports, and earnings notes.
No research on NUVA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NUVA report →Similar companies
Peers in the same neighborhood.